ConvaTec Group Plc Share Price
Stocks
CTEC
GB00BD3VFW73
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Market Closed -
London S.E.
09:05:21 16/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 238.00 GBX | +0.51% |
|
+8.18% | -2.14% |
| 15/10 | Convatec non-executive director Viebke buys 24,000 shares | AN |
| 12/10 | Stocks up ahead of US earnings but oil stays high | AN |
| Market Cap | 620.54Cr 551.6Cr 511.26Cr 465.16Cr 877.77Cr 59TCr 891.85Cr 6.15TCr 2.41TCr 31TCr 2.33TCr 2.28TCr 98TCr | P/E 2026 * |
24.6x | P/E 2027 * | 16.9x |
|---|---|---|---|---|---|
| Enterprise Value | 760.77Cr 676.25Cr 626.79Cr 570.28Cr 1.08TCr 72TCr 1.09TCr 7.53TCr 2.95TCr 38TCr 2.86TCr 2.79TCr 1,20100Cr | EV / Sales 2026 * |
2.98x | EV / Sales 2027 * | 2.72x |
| Free-Float |
95.08% | Yield 2026 * |
2.51% | Yield 2027 * | 2.86% |
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| CTEC | Delayed | |
CBOE
| CTEC | Real-time | |
|
OTC Markets
| CNVVF | Delayed | |
|
Tradegate
| 2CV | Real-time | |
|
Deutsche Boerse AG
| 2CV | Delayed | |
|
Börse Stuttgart
| 2CV | Delayed | |
|
Boerse Muenchen
| 2CV | Real-time |
Last Transcript: ConvaTec Group Plc
| 1 day | +0.51% | ||
| 1 week | +8.18% | ||
| Current month | +9.68% | ||
| 1 month | +10.08% | ||
| 3 months | +11.53% | ||
| 6 months | +0.59% | ||
| Current year | -2.14% |
| 1 week | 221 |  | 239.6 |
| 1 month | 209.2 | | 239.6 |
| Current year | 193 | | 259.3 |
| 1 year | 193 | | 259.3 |
| 3 years | 193 | | 311.2 |
| 5 years | 165.3 | | 311.2 |
| 10 years | 113.25 | | 349.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jonathan Mason
CEO | Chief Executive Officer | 62 | 04/08/2025 |
Fiona Ryder
DFI | Director of Finance/CFO | 51 | 04/08/2025 |
Peter Jarvis
COO | Chief Operating Officer | - | 01/06/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Margaret Ewing
BRD | Director/Board Member | 71 | 14/08/2017 |
John McAdam
CHM | Chairman | 78 | 30/09/2019 |
Brian May
BRD | Director/Board Member | 62 | 02/03/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 13/10/26 | Buy | Director | 24,400 | 0.0013% | ||
| 26/05/26 | Buy | Chief Executive Officer | 50,000 | 0.0026% | ||
| 26/05/26 | Buy | Chief Financial Officer | 24,993 | 0.0013% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.51% | +8.18% | -1.90% | +17.82% | 620.54Cr | |
| +0.20% | +5.31% | -17.82% | +13.79% | 18TCr | |
| -0.73% | +7.09% | -0.31% | +32.06% | 12TCr | |
| +0.49% | +6.25% | -20.20% | +11.58% | 11TCr | |
| +3.83% | +5.50% | -44.18% | -6.77% | 7.98TCr | |
| -0.14% | +5.27% | +6.74% | +82.45% | 6.51TCr | |
| +2.79% | +2.37% | +15.93% | +68.64% | 5.43TCr | |
| -1.04% | +4.35% | +3.50% | -26.18% | 5.22TCr | |
| +2.41% | +8.18% | -12.08% | +30.45% | 4.41TCr | |
| -1.90% | +2.29% | +29.72% | +8.98% | 3.25TCr | |
| Average | +0.72% | +5.58% | -4.06% | +23.28% | 7.45TCr | |
| Weighted average by Cap. | +0.62% | +5.61% | -9.63% | +22.10% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 255.37Cr 227Cr 210.39Cr 191.42Cr 361.22Cr 24TCr 367.01Cr 2.53TCr 991.57Cr 13TCr 958.39Cr 937.99Cr 40TCr | 273.22Cr 242.87Cr 225.11Cr 204.81Cr 386.48Cr 26TCr 392.68Cr 2.71TCr 1.06TCr 14TCr 1.03TCr 1TCr 43TCr |
| Net income | 25Cr 22Cr 21Cr 19Cr 35Cr 2.37TCr 36Cr 247.35Cr 97Cr 1.24TCr 94Cr 92Cr 3.94TCr | 36Cr 32Cr 30Cr 27Cr 52Cr 3.46TCr 52Cr 360.71Cr 141.43Cr 1.8TCr 136.7Cr 133.79Cr 5.75TCr |
| Net Debt | 140.23Cr 124.65Cr 115.53Cr 105.11Cr 198.36Cr 13TCr 201.54Cr 1.39TCr 544.49Cr 6.94TCr 526.28Cr 515.07Cr 22TCr | 122.37Cr 108.77Cr 100.82Cr 92Cr 173.09Cr 12TCr 175.87Cr 1.21TCr 475.14Cr 6.06TCr 459.24Cr 449.47Cr 19TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/26/16 | GBX 238.00 | +0.51% | 72,61,498 |
| 15/26/15 | GBX 236.80 | +0.94% | 2,42,81,065 |
| 14/26/14 | GBX 234.60 | +1.65% | 4,48,89,089 |
| 13/26/13 | GBX 230.80 | +0.09% | 1,18,17,903 |
| 12/26/12 | GBX 230.60 | +4.82% | 66,11,650 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CTEC Stock
Select your edition
All financial news and data tailored to specific country editions
